Endeavor Pharmaceuticals
Records under this name other than patents Endeavor Pharmaceuticals holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Endeavor Pharmaceuticals
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,660,726 | Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same Formerly held Term ended Term ended Mar 8, 2021 · USPTO record | Term ended | Term ended Mar 8, 2021 | USPTO record |
| US 6,844,334 | (3) and (6) substitued estrogenic compounds Formerly held Term ended Term ended Mar 8, 2021 · USPTO record | Term ended | Term ended Mar 8, 2021 | USPTO record |
| US 7,427,609 | Treatment of conditions relating to hormone deficiencies by administration of progestins Formerly held Lapsed on the fee record Ended Sep 23, 2020 · USPTO record | Lapsed on the fee record | Ended Sep 23, 2020 | USPTO record |
| US 7,179,799 | (3) and (6) substituted estrogenic compounds Formerly held Lapsed on the fee record Ended Feb 20, 2019 · USPTO record | Lapsed on the fee record | Ended Feb 20, 2019 | USPTO record |
| US 6,992,075 | C(14) estrogenic compounds Formerly held Lapsed on the fee record Ended Jan 31, 2018 · USPTO record | Lapsed on the fee record | Ended Jan 31, 2018 | USPTO record |
| US 6,855,703 | Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds Formerly held Lapsed on the fee record Ended Feb 15, 2017 · USPTO record | Lapsed on the fee record | Ended Feb 15, 2017 | USPTO record |
| US 6,787,659 | Process for the production of oxandrolone Formerly held Lapsed on the fee record Ended Sep 7, 2016 · USPTO record | Lapsed on the fee record | Ended Sep 7, 2016 | USPTO record |
| US 7,297,801 | Process for the production of 2-oxa-3-one androstane derivatives Lapsed on the fee record Ended Nov 20, 2015 · USPTO record | Lapsed on the fee record | Ended Nov 20, 2015 | USPTO record |
| US 5,928,668 | Method for dry blend compression of medicaments Formerly held Term ended Term ended no later than Jul 27, 2019 · Low confidence | Term ended | Term ended no later than Jul 27, 2019 | Low confidence |
| US 5,976,570 | Method for preparing low dose pharmaceutical products Formerly held Term ended Term ended no later than Nov 2, 2019 · Low confidence | Term ended | Term ended no later than Nov 2, 2019 | Low confidence |